INFINITY PHARMACEUTICALS, INC. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2012-09-24. The offering totals $78.5M, of which $78.5M was reported sold. Industry: Biotechnology.
| Name | Role | Location |
|---|---|---|
| Martin H Babler | Director | Cambridge, MA |
| Anthony B. Evnin | Director | Cambridge, MA |
| Gwen A. Fyfe | Director | Cambridge, MA |
| Steve H Holtzman | Director | Cambridge, MA |
| Eric S. Lander | Director | Cambridge, MA |
| Patrick P Lee | Director | Cambridge, MA |
| Thomas J. Lynch | Director | Cambridge, MA |
| Adelene Q. Perkins | Director | Cambridge, MA |
| Norman C. Selby | Director | Cambridge, MA |
| Ian F. Smith | Director | Cambridge, MA |
| Michael C. Venuti | Director | Cambridge, MA |
| Julian Q. Adams | Executive Officer | Cambridge, MA |
| Vito J. Palombella | Executive Officer | Cambridge, MA |
| Adelene Q. Perkins | Executive Officer | Cambridge, MA |
| Pedro J. Santabarbara | Executive Officer | Cambridge, MA |